Characterization of a putative GTP-binding protein as a novel tumor marker.
Characterization of a putative GTP-binding protein as a novel tumor marker.
批准号:
7266108
负责人:
YING HUANG
金额:
$7.83万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-12 至 2009-05-31
关键词:
ApoptosisCell DeathColorectalColorectal CancerColorectal NeoplasmsConserved SequenceDNA DamageDepthDevelopmentDown-RegulationEventFutureGTP BindingGTP-Binding ProteinsGenesGenotoxic StressGrowthHumanLinkMalignant NeoplasmsMediatingMediator of activation proteinMessenger RNAMolecularMolecular Mechanisms of ActionNormal tissue morphologyNumbersOncogenicOutcome StudyPlayProcessProtein OverexpressionProtein p53ProteinsRoleSignal PathwaySignal TransductionSpecimenStressTP53 geneTestingTissue MicroarrayTitleTranslationsTumor Markersbasecancer typecell growthmRNA Expressionmetaplastic cell transformationmolecular massnovelresponsetraffickingtumortumorigenesis
中文摘要
描述(由申请人提供):
研究提出了一种新的基因DOC 45(DNA损伤调节过表达的癌症45),编码一个高度保守的推定GTP结合蛋白的45 kDa的特征。GTP结合蛋白控制各种重要过程,包括蛋白质翻译和运输、信号转导、细胞生长、存活和转化。这里提出的初步结果表明,DOC 45 mRNA表达下调的遗传毒性应激(DNA损伤),以及肿瘤抑制基因p53。然而,遗传毒性应激后DOC 45下调似乎也以不依赖于p53的方式发生。此外,DOC 45在包括结直肠癌在内的几种癌症类型中过表达。基于我们的初步结果,我们假设DOC 45可能是一个高价值的肿瘤标志物,DNA损伤和p53对其的下调可能是DNA损伤和p53介导的生长抑制和/或细胞死亡的关键事件。此外,DOC 45表达和DOC 45介导的信号传导事件的改变可能是选定的人类恶性肿瘤(包括结直肠癌)发生和/或进展的机制的一部分。我们提出了两个具体的目标,以进一步表征DOC 45。具体目的1是研究DOC 45在原发性结直肠癌和匹配的正常组织中在mRNA和蛋白水平上的表达。具体目标2是确定DOC 45的GTP结合潜力及其在细胞对DNA损伤的反应中的作用。这些研究的结果将提供有关DOC 45作为高价值分子肿瘤标志物的实用性及其在DNA损伤反应中的作用的有价值的信息,特别是在人类结直肠癌的发展和/或进展的背景下。
英文摘要
DESCRIPTION (provided by applicant):
Studies are proposed to characterize a novel gene DOC45 (DNA damage-regulated overexpressed in cancer 45) that encodes a highly conserved putative GTP-binding protein of 45 kDa. GTP-binding proteins control various important processes including, protein translation and trafficking, signal transduction, cell growth, survival and transformation. Preliminary results presented here indicate that DOC45 mRNA expression is down-regulated by genotoxic stress (DNA damage) as well as by tumor suppressor p53. However, DOC45 down-regulation following genotoxic stress appears to also occur in a p53-independent manner. In addition, DOC45 is overexpressed in several cancer types including colorectal cancer. Based on our preliminary results, we hypothesize that DOC45 could be a high-value tumor marker and its down-regulation by DNA damage and p53 may be a critical event for DNA damage and p53-mediated growth inhibition and/or cell death. Furthermore, alterations in DOC45 expression and DOC45-mediated signaling events could be part of the mechanisms underlying the development and/or progression of selected human malignancies including colorectal cancer. We have proposed two specific aims to further characterize DOC45. Specific Aim 1 is to investigate the expression of DOC45, at mRNA as well as protein levels, in primary colorectal cancers and matching normal tissues. Specific Aim 2 is to determine the GTP-binding potential of DOC45 and its role in cellular response to DNA damage. The outcome of these studies will provide valuable information about the utility of DOC45 as a high-value molecular tumor marker, and its role in DNA damage response particularly in context to the development and/or progression of human colorectal cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:8209218
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7599214
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7467584
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:8018083
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Role of a Novel Lysophospholipase in Tumorigenesis
-
批准号:7759205
-
项目类别:
-
资助金额:$29.32万
-
财政年份:2008
-
负责人:YING HUANG
-
依托单位:
Characterization of a putative GTP-binding protein as a novel tumor marker.
-
批准号:7446107
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2007
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel nuclear Rab protein
-
批准号:7093752
-
项目类别:
-
资助金额:$11.78万
-
财政年份:2006
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel nuclear Rab protein
-
批准号:7230197
-
项目类别:
-
资助金额:$11.55万
-
财政年份:2006
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel ER membrane protein SPOC
-
批准号:6874380
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2004
-
负责人:YING HUANG
-
依托单位:
Characterization of a novel ER membrane protein SPOC
-
批准号:6762103
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2004
-
负责人:YING HUANG
-
依托单位:
Dielectrophoretic Separator for Cell/Pathogen Separation
-
批准号:6585295
-
项目类别:
-
资助金额:$14.75万
-
财政年份:2003
-
负责人:YING HUANG
-
依托单位:
Characterization of a Novel Lysophospholipase
-
批准号:6521908
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2002
-
负责人:YING HUANG
-
依托单位:
Characterization of a Novel Lysophospholipase
-
批准号:6637079
-
项目类别:
-
资助金额:$15.2万
-
财政年份:2002
-
负责人:YING HUANG
-
依托单位:
国内基金
海外基金
炎性反应中巨噬细胞激活诱导死亡(activation-induced cell death,AICD)的机理研究
-
批准号:30330260
-
项目类别:重点项目
-
资助金额:105.0万元
-
批准年份:2003
-
负责人:顾军
-
依托单位: